BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 32712122)

  • 1. Hyperglycemia is a strong predictor of poor prognosis in COVID-19.
    Liu SP; Zhang Q; Wang W; Zhang M; Liu C; Xiao X; Liu Z; Hu WM; Jin P
    Diabetes Res Clin Pract; 2020 Sep; 167():108338. PubMed ID: 32712122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
    Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
    Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
    Zhang J; Kong W; Xia P; Xu Y; Li L; Li Q; Yang L; Wei Q; Wang H; Li H; Zheng J; Sun H; Xia W; Liu G; Zhong X; Qiu K; Li Y; Wang H; Wang Y; Song X; Liu H; Xiong S; Liu Y; Cui Z; Hu Y; Chen L; Pan A; Zeng T
    Front Endocrinol (Lausanne); 2020; 11():525. PubMed ID: 32754119
    [No Abstract]   [Full Text] [Related]  

  • 4. Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study.
    Li Y; Han X; Alwalid O; Cui Y; Cao Y; Liu J; Gu J; Wang L; Fan Y; Shi H
    Diabetes Res Clin Pract; 2020 Aug; 166():108299. PubMed ID: 32623030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
    Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ
    Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictors of Mortality in Adults Admitted with COVID-19: Retrospective Cohort Study from New York City.
    Chilimuri S; Sun H; Alemam A; Mantri N; Shehi E; Tejada J; Yugay A; Nayudu SK
    West J Emerg Med; 2020 Jul; 21(4):779-784. PubMed ID: 32726241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study.
    Wang S; Ma P; Zhang S; Song S; Wang Z; Ma Y; Xu J; Wu F; Duan L; Yin Z; Luo H; Xiong N; Xu M; Zeng T; Jin Y
    Diabetologia; 2020 Oct; 63(10):2102-2111. PubMed ID: 32647915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
    Singh AK; Singh R
    Diabetes Res Clin Pract; 2020 Sep; 167():108382. PubMed ID: 32853686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea.
    Kim MK; Jeon JH; Kim SW; Moon JS; Cho NH; Han E; You JH; Lee JY; Hyun M; Park JS; Kwon YS; Choi YK; Kwon KT; Lee SY; Jeon EJ; Kim JW; Hong HL; Kwon HH; Jung CY; Lee YY; Ha E; Chung SM; Hur J; Ahn JH; Kim NY; Kim SW; Chang HH; Lee YH; Lee J; Park KG; Kim HA; Lee JH
    Diabetes Metab J; 2020 Aug; 44(4):602-613. PubMed ID: 32794386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study.
    Chang MC; Hwang JM; Jeon JH; Kwak SG; Park D; Moon JS
    Endocrinol Metab (Seoul); 2020 Sep; 35(3):595-601. PubMed ID: 32842719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19.
    Yang P; Wang N; Wang J; Luo A; Gao F; Tu Y
    J Med Virol; 2021 Apr; 93(4):2168-2176. PubMed ID: 33073361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
    Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
    Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome.
    Roncon L; Zuin M; Rigatelli G; Zuliani G
    J Clin Virol; 2020 Jun; 127():104354. PubMed ID: 32305882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in Spanish COVID-19 patients: A case series from Barcelona.
    Sisó-Almirall A; Kostov B; Mas-Heredia M; Vilanova-Rotllan S; Sequeira-Aymar E; Sans-Corrales M; Sant-Arderiu E; Cayuelas-Redondo L; Martínez-Pérez A; García-Plana N; Anguita-Guimet A; Benavent-Àreu J
    PLoS One; 2020; 15(8):e0237960. PubMed ID: 32822413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features of severe COVID-19: A systematic review and meta-analysis.
    Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D
    Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
    Fadini GP; Morieri ML; Boscari F; Fioretto P; Maran A; Busetto L; Bonora BM; Selmin E; Arcidiacono G; Pinelli S; Farnia F; Falaguasta D; Russo L; Voltan G; Mazzocut S; Costantini G; Ghirardini F; Tresso S; Cattelan AM; Vianello A; Avogaro A; Vettor R
    Diabetes Res Clin Pract; 2020 Oct; 168():108374. PubMed ID: 32805345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?
    Sardu C; D'Onofrio N; Balestrieri ML; Barbieri M; Rizzo MR; Messina V; Maggi P; Coppola N; Paolisso G; Marfella R
    Diabetes Care; 2020 Jul; 43(7):1408-1415. PubMed ID: 32430456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.